BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7095282)

  • 21. [Puerperal inhibition of lactation with metergoline or bromocriptine].
    Fischer T; Streitmatter A; Gerede A; Frauendorf A; Krause M; Feige A
    Z Geburtshilfe Neonatol; 1995; 199(3):111-5. PubMed ID: 7553254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C; Leke R
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of lactation. A comparison of bromocriptine and prostaglandin E2.
    England MJ; Tjallinks A; Hofmeyr J; Harber J
    J Reprod Med; 1988 Jul; 33(7):630-2. PubMed ID: 3172062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of aluminium on duodenal calcium transport in pregnant and lactating rats treated with bromocriptine.
    Orihuela D
    J Inorg Biochem; 2007 Sep; 101(9):1270-4. PubMed ID: 17629566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of a new anti-prolactin agent, Parlodel (CB 154) in the inhibition of postpartum lactation].
    Notter A; Panisset JF
    Lyon Med; 1977 Dec; 238(20):547-8. PubMed ID: 599954
    [No Abstract]   [Full Text] [Related]  

  • 26. [Physiology of lactation and weaning. II].
    Brundin J
    Katilolehti; 1978 Nov; 83(11):418-21. PubMed ID: 32420
    [No Abstract]   [Full Text] [Related]  

  • 27. The study of a physiological significance of prolactin in the regulation of calcium metabolism during pregnancy and lactation in rats.
    Lotinun S; Limlomwongse L; Krishnamra N
    Can J Physiol Pharmacol; 1998 Feb; 76(2):218-28. PubMed ID: 9635163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accumulation of prolactin by maternal milk and its transfer to circulation of neonatal rat--a review.
    Grosvenor CE; Whitworth NS
    Endocrinol Exp; 1983 Oct; 17(3-4):271-82. PubMed ID: 6606567
    [No Abstract]   [Full Text] [Related]  

  • 29. Luteal 20alpha-hydroxy steroid dehydrogenase and the formation of delta4-3-oxo steroids in the rat after weaning or treatment with 2-bromo-alpha-ergocryptine during lactation.
    Rodway RG; Kuhn NJ
    Biochem J; 1975 Dec; 152(3):445-8. PubMed ID: 1227499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of bromocriptine treatment during early pregnancy on postpartum maternal behaviors in rats.
    Price AK; Bridges RS
    Dev Psychobiol; 2014 Sep; 56(6):1431-7. PubMed ID: 24889499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study.
    Utian WH; Begg G; Vinik AI; Paul M; Shuman L
    Br J Obstet Gynaecol; 1975 Sep; 82(9):755-9. PubMed ID: 1101946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Our experience in the inhibition of lactation (Controlled clinical study with bromocriptine, methergoline and pyridoxine)].
    Vecchione A; Baccolo M
    Riv Ital Ginecol; 1980; 59(2-3):311-9. PubMed ID: 7020052
    [No Abstract]   [Full Text] [Related]  

  • 33. Lactation suppression with bromocriptine.
    Hutchison P; Sill H
    N Z Med J; 1981 Oct; 94(694):309-10. PubMed ID: 7033847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice.
    Elahi MM; Cagampang FR; Mukhtar D; Anthony FW; Ohri SK; Hanson MA
    Br J Nutr; 2009 Aug; 102(4):514-9. PubMed ID: 19203419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latency and duration of the effects of bromocriptine and prolactin on milk secretion in lactating rabbits.
    Mena F; Martínez-Escalera G; Aguayo D; Clapp C; Grosvenor CE
    J Endocrinol; 1982 Sep; 94(3):389-95. PubMed ID: 7119648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of human and murine antisense oligonucleotide inhibitors of ICAM-1 on reproductive performance, fetal development, and post-natal development in mice.
    Henry SP; Denny KH; Templin MV; Yu RZ; Levin AA
    Birth Defects Res B Dev Reprod Toxicol; 2004 Dec; 71(6):359-67. PubMed ID: 15617021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of puerperal lactation. A double blind study of bromocriptine and placebo.
    Dewhurst CJ; Harrison RF; Biswas S
    Acta Obstet Gynecol Scand; 1977; 56(4):327-31. PubMed ID: 341635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined pre- and postnatal environmental enrichment programs the HPA axis differentially in male and female rats.
    Welberg L; Thrivikraman KV; Plotsky PM
    Psychoneuroendocrinology; 2006 Jun; 31(5):553-64. PubMed ID: 16434144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Puerperal hypertension, stroke, and seizures after suppression of lactation with bromocriptine.
    Katz M; Kroll D; Pak I; Osimoni A; Hirsch M
    Obstet Gynecol; 1985 Dec; 66(6):822-4. PubMed ID: 3840873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.